FIELD: medicine.
SUBSTANCE: method of producing a recombinant vaccine provides producing chimeric proteins or DNA expressing genes of these chimeric proteins consisting of three or more functional parts. These parts are active material of the vaccine and presented by a pathogenic microorganism antigen, a TLR-receptor ligand and ligants for receptors transferring signal through ITAM-motives. The chimeric proteins are directly used as vaccines for human and animal immunisation. For the vaccines representing DNA coding the chimeric protein, recombinant adenovirus particles and/or plasmid DNA are used as a carrier.
EFFECT: vaccination accompanying preventive treatment of infectious diseases.
29 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BROAD-SPECTRUM M2 PROTEIN ECTODOMAIN AVIAN INFLUENZA TYPE A VACCINE | 2014 |
|
RU2571944C1 |
| RECOMBINANT TRIVALENT INFLUENZA VACCINE | 2012 |
|
RU2485973C1 |
| IMPROVED VECTOR EXPRESSING TOLL-LIKE RECEPTOR AND AGONIST, AND USE IN CANCER THERAPY | 2014 |
|
RU2682762C2 |
| COMPOSITION FOR AMPLIFICATION OF TRANSGENE EXPRESSION IN EUCARIOTIC CELLS, AND METHOD FOR INCREASING GENERATION OF TARGET PROTEIN CODED WITH TRANSGENE | 2013 |
|
RU2546249C2 |
| FUSION PROTEIN, DNA, GENETIC CONSTRUCT, RECOMBINANT CELL, FUSION PROTEIN-BASED VACCINE FOR TUBERCULOSIS PREVENTION AND TREATMENT (VERSIONS) | 2015 |
|
RU2615440C2 |
| GENE THERAPY PREPARATION FCU1-BSFM/PP FOR TREATING SOLID TUMOURS | 2023 |
|
RU2824977C1 |
| ANTI-TUMOR EFFECTS OF A VIRAL VECTOR ENCODING A TOLL-LIKE RECEPTOR AND A TOLL-LIKE RECEPTOR AGONIST | 2017 |
|
RU2741228C2 |
| CHLAMYDIAL VACCINE AND METHOD FOR ITS PREPARATION | 2016 |
|
RU2676768C2 |
| METHOD TO OBTAIN CHEMERIC RECOMBINANT PROTEIN fliC:pagN | 2015 |
|
RU2627602C2 |
| MEDICAMENT | 2016 |
|
RU2709015C2 |
